12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

NexoBrid regulatory update

EMA's CHMP issued a positive opinion recommending approval of Teva's NexoBrid cutaneous powder and gel to...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >